000 | 01013 a2200301 4500 | ||
---|---|---|---|
005 | 20250517024024.0 | ||
264 | 0 | _c20150601 | |
008 | 201506s 0 0 eng d | ||
022 | _a1474-1784 | ||
024 | 7 |
_a10.1038/nrd4571 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSyed, Basharut A | |
245 | 0 | 0 |
_aThe breast cancer market. _h[electronic resource] |
260 |
_bNature reviews. Drug discovery _cApr 2015 |
||
300 |
_a233-4 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAntineoplastic Agents _xeconomics |
650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aCancer Vaccines _xeconomics |
650 | 0 | 4 |
_aDrug Industry _xeducation |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHealth Care Sector _xeconomics |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunotherapy _xeconomics |
650 | 0 | 4 |
_aReceptor, ErbB-2 _xgenetics |
773 | 0 |
_tNature reviews. Drug discovery _gvol. 14 _gno. 4 _gp. 233-4 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/nrd4571 _zAvailable from publisher's website |
999 |
_c24761824 _d24761824 |